Gf Fund Management Co. Ltd. Xeris Biopharma Holdings, Inc. Transaction History
Gf Fund Management Co. Ltd.
- $4.62 Trillion
- Q4 2024
A detailed history of Gf Fund Management Co. Ltd. transactions in Xeris Biopharma Holdings, Inc. stock. As of the latest transaction made, Gf Fund Management Co. Ltd. holds 3,130 shares of XERS stock, worth $12,426. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,130Holding current value
$12,426% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding XERS
# of Institutions
163Shares Held
61.5MCall Options Held
34.2KPut Options Held
21.7K-
Black Rock Inc. New York, NY10.3MShares$41 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.9MShares$31.4 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA3.35MShares$13.3 Million0.0% of portfolio
-
State Street Corp Boston, MA3.34MShares$13.3 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.88MShares$11.4 Million0.0% of portfolio
About Xeris Biopharma Holdings, Inc.
- Ticker XERS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 135,956,992
- Market Cap $540M
- Description
- Xeris Biopharma Holdings, Inc., a biopharmaceutical company, engages in developing and commercializing therapies for patient populations in endocrinology, neurology, and gastroenterology. The company markets Gvoke, a ready-to-use liquid glucagon for the treatment of severe hypoglycemia; and Keveyis, a therapy for the treatment of hyperkalemic, h...